Cloridrato de Bromexina EMS indications
Cloridrato de Bromexina EMS hydrochloride SYRUP indicated for cough associated with wheeziness (bronchospasm) and tenacious phlegm (sputum).
Uses of Cloridrato de Bromexina EMS in details
Cloridrato de Bromexina EMS is used to treat breathing difficulties caused by excessive mucus secretions in the air passages associated with respiratory tract infections.
Cloridrato de Bromexina EMS description
Each tablet also contains lactose, maize or potato starch, gelatine and magnesium stearate as excipients.
The oral/inhalation solution also contains tartaric acid and methyl parahydroxybenzoate as excipients.
The syrup also contains tartaric acid, benzoic acid, sodium carboxymethylcellulose, glycerol, sorbitol solution, pharma flavor and ethanol as excipients.
Each capsule also contains lactose, cornstarch and magnesium stearate as excipients.
Cloridrato de Bromexina EMS HCl is N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)amine hydrochloride.
Cloridrato de Bromexina EMS dosage
Unless otherwise prescribed, the following doses are recommended:
Tablet: Adults and Children >12 years: 8 mg (1 tab) thrice daily; 6-12 years: 4 mg (½ tab) thrice daily; 2-6 years: 4 mg (½ tab) twice daily.
Oral Solution:
Adults and Children >12 years: 4 mL thrice daily; 6-12 years: 2 mL thrice daily; 2-6 years: 20 drops thrice daily; <2 years: 10 drops thrice daily.Inhalation Solution (with aerosol apparatus): It is generally recommended to warm inhalation solution to body temperature before inhalation. Patients with bronchial asthma may be advised to commencing inhalation after they have taken their regular bronchospasmolytic therapy.
Adults: 4 mL. Children >12 years: 2 mL; 6-12 years: 1 mL; 2-6 years: 10 drops; <2 years: 5 drops. All doses to be taken twice daily.
The solution may be diluted 1:1 in physiological saline solution. In order to avoid precipitation, the solution should be inhaled immediately after mixing. The combined administration of inhalation and oral application intensifies the effect, and is especially suited for the commencement of treatment in cases where the full effect is to be reached quickly.
Syrup: Adults and Children >12 years: 5 ml (1 tsp) thrice daily.
At commencement of treatment, it may be necessary to increase the total daily dose up to 48 mg in adults.
The syrup is sugar-free and therefore suitable for diabetics and small children.
Ampoule: Severe cases, before and after surgical intervention: 1 amp SC, IM or IV (duration of injection: 2-3 min) 2-3 times daily.
Capsule: Adults: 1 cap 3 times daily.
It is recommended for the initial phase of treatment usually lasting not more than a week.
Patients being treated with Cloridrato de Bromexina EMS should be notified of an expected increase in the flow of secretions.
Cloridrato de Bromexina EMS interactions
A reduction in dose of cardiac glycosides (e.g. digitalis) and quinidine might become necessary in patients suffering from congestive cardiac failure because of the positive inotropic effect of orciprenaline sulphate.
Cloridrato de Bromexina EMS hydrochloride SYRUP should not be administered concomitantly with beta-blocking agents, due to orciprenaline’s reversal of anti-hypertensive action.
The concomitant use of other sympathomimetic agents should be carefully controlled to avoid potentiation of effects.
Cloridrato de Bromexina EMS side effects
Cloridrato de Bromexina EMS’s pharmacological action may lead to gastric irritation. A transient rise in serum aminotransferase values have been reported due to Cloridrato de Bromexina EMS.
Orciprenaline sulphate, as a sympathomimetic agent, may precipitate a wide range of adverse effects. Side-effects include fear; anxiety, restlessness, tremor, insomnia, confusion, irritability, weakness and psychotic states. Appetite may be reduced and nausea and vomiting may occur. A rise in blood pressure which may produce cerebral haemorrhage and pulmonary oedema, tachycardia and cardiac arrhythmias, anginal pain, palpitations, and cardiac arrest. Hypotension with dizziness and fainting and flushing may occur. Other effects that may occur include difficulty in micturition and urinary retention; dyspnoea; weakness; headache; disturbances of glucose metabolism; sweating and hypersalivation. Muscle cramps or twitching or unpleasant taste may occur.
Cloridrato de Bromexina EMS contraindications
Cloridrato de Bromexina EMS hydrochloride SYRUP is contra-indicated in patients with known hypersensitivity to sympathomimetic amines or any of the other ingredients; hypertrophic obstructive cardiomyopathy; and tachyarrhythmia.
Sympathomimetics, such as orciprenaline sulphate, may interact with monoamine oxidase inhibitors (MAOI), and therefore Cloridrato de Bromexina EMS hydrochloride SYRUP should not be given to patients receiving such treatment or within 14 days of MAOI treatment termination.
Safety in pregnancy and lactation has not been established.
Active ingredient matches for Cloridrato de Bromexina EMS:
Bromhexine in Brazil.
List of Cloridrato de Bromexina EMS substitutes (brand and generic names) | Sort by popularity |
| Unit description / dosage (Manufacturer) | Price, USD |
| Cloridrato de Bromexina Nova Quimica (Brazil) | |
| Cof D | |
| Cof D 60 ml Syrup (Pfiscar India Limited) | $ 0.02 |
| Cofal (India) | |
| Cofal Bromhexine hydrochloride 2 mg, Terbutaline sulphate 1.25 mg, Guaiphenesin 50 mg. SYR / 100ml (Alna Bio) | $ 0.49 |
| 100ml (Alna Bio) | $ 0.49 |
| COFAL syr 100ml (Alna Bio) | $ 0.49 |
| Cofdex Syr (India) | |
| Cofdex Syr Bromhexine hydrochloride 4 mg, Dextromethorphan Hydrobromide5 mg, ammonium chloride 50 mg, Menthol 2.5 mg. SYR / 100ml (Cipla) | $ 0.42 |
| 100ml (Cipla) | $ 0.42 |
| COFDEX SYR syr 100ml (Cipla) | $ 0.42 |
| Cofex T | |
| Cofex T 100 ml Syrup (Paradigm Healthcare) | $ 0.02 |
| Cofish AX | |
| Cofish AX 100 ml Syrup (Moreish Pharmaceuticals Pvt. Ltd.) | $ 0.02 |
| Coflyt (Bangladesh) | |
| Cofmesin (Japan) | |
| Cofocura (India) | |
| Cofocura Terbutaline sulphate 1.25 mg, Bromhexine hydrochloride 4 mg, Guaiphenesin 50 mg, Menthol2.5 mg/5 mL. SYR / 100ml (Daniel Pasteur) | $ 0.51 |
| Cofocura Terbutaline sulphate 1.25 mg, Bromhexine hydrochloride 4mg, Guaiphenesin 50 mg, Menthol2.5 mg/5 mL. SYR / 60ml (Daniel Pasteur) | $ 0.35 |
| 100ml (Daniel Pasteur) | $ 0.51 |
| 60ml (Daniel Pasteur) | $ 0.35 |
| Cofocura 60 ml Syrup (Daniel Pasteur) | $ 0.03 |
| Cofocura 100 ml Syrup (Daniel Pasteur) | $ 0.03 |
| COFOCURA syr 100ml (Daniel Pasteur) | $ 0.51 |
| COFOCURA syr 60ml (Daniel Pasteur) | $ 0.35 |
| Cofpet DX | |
| Cofpet DX 120 ml Syrup (Vista Healthcare) | $ 0.02 |
| Cofpet-DX (India) | |
| Cofpet-DX Bromhexine hydrochloride 4 mg, Dextromethorphan hydrobromide5 mg. SYR / 120ml (Vista HC) | $ 0.38 |
| 120ml (Vista HC) | $ 0.38 |
| COFPET-DX syr 120ml (Vista HC) | $ 0.38 |
| Cofq X | |
| Cofq X 100 ml Syrup (Cipla Limited) | $ 0.02 |
| Cofq-X (India) | |
| Cofq-X Terbutaline sulphate 1.25 mg, Bromhexine hydrochloride 4 mg, Guaiphenesin 50 mg/5 mL. LIQD / 100ml (Cipla) | $ 0.36 |
| 100ml (Cipla) | $ 0.36 |
| COFQ-X oral liqd 100ml (Cipla) | $ 0.36 |
| Cofrav | |
| Cofrav 100 ml Syrup (Ravian Life Sciences (P) Ltd) | $ 0.03 |
| Cofree Tablet | |
| Cofree Tablet (Stadia Biotech) | $ 0.04 |
| Coftex-BT (India) | |
| Coftex-BT Bromhexine hydrochloride 8 mg, Terbutaline sulphate 2.5 mg, Menthol 5 mg, Guaiphenesin 100mg. SYR / 100ml (Santiago) | |
| 100ml (Santiago) | |
| COFTEX-BT syr 100ml (Santiago) | $ 0.66 |
| Cohexine (Thailand) | |
| Cohexine 8 mg x 50 x 10's (Community Pharm PCL) | |
| Cohexine 4 mg/5 mL x 60 mL (Community Pharm PCL) | |
| Cohexine syr 4 mg/5 mL 60 mL x 1's (Community Pharm PCL) | |
| Cohexine tab 8 mg 50 x 10's (Community Pharm PCL) | |
| Cold-Relieve Syr (India) | |
| Cold-Relieve Syr Phenylephrine hydrochloride2.5 mg, Chlorpheniraminemaleate 1.25 mg, Bromhexinehydrochloride 4 mg. SYR / 60ml (Medico HC) | $ 0.34 |
| 60ml (Medico HC) | $ 0.34 |
| COLD-RELIEVE SYR syr 60ml (Medico HC) | $ 0.34 |
| Copod B | |
| Copod B 100 ml Syrup (Mepfarma (Alna Biotech)) | $ 0.02 |
| Copod-B (India) | |
| Copod-B Bromhexine hydrochloride 2 mg, Terbutaline sulphate 1.25 mg, Guaiphenesin 50 mg. SYR / 100ml (Mepfarma) | $ 0.49 |
See 1877 substitutes for Cloridrato de Bromexina EMS | |
References
- PubChem. "bromhexine". https://pubchem.ncbi.nlm.nih.gov/com... (accessed September 17, 2018).
- DrugBank. "Bromhexine". http://www.drugbank.ca/drugs/DB09019 (accessed September 17, 2018).
- MeSH. "Expectorants". https://www.ncbi.nlm.nih.gov/mesh/68... (accessed September 17, 2018).
Reviews
The results of a survey conducted on ndrugs.com for Cloridrato de Bromexina EMS are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Cloridrato de Bromexina EMS. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.User reports
Consumer reported useful
No survey data has been collected yetConsumer reported price estimates
No survey data has been collected yetConsumer reported time for results
No survey data has been collected yetConsumer reported age
No survey data has been collected yetConsumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
